» Articles » PMID: 35613197

Prognostic Value of Aortic Stiffness Using Cardiovascular Magnetic Resonance in The Elderly with Known or Suspected Coronary Artery Disease

Overview
Date 2022 May 25
PMID 35613197
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Aortic stiffness is established as a marker of cardiovascular disease. Cardiovascular magnetic resonance (CMR) provides a comprehensive assessment of aortic stiffness and myocardial ischemia in a single examination. However, prognostic data concerning aortic stiffness in elderly patients remain limited.

Objective: To determine the prognostic value of aortic stiffness using CMR-based pulse wave velocity (PWV) in elderly patients with known or suspected coronary artery disease (CAD).

Methods: This study enrolled consecutive patients aged >70 referred for adenosine stress perfusion CMR including PWV between 2010 and 2014. Patients were followed up for occurrence of major adverse cardiovascular events (MACE), including cardiac mortality, nonfatal myocardial infarction, hospitalization for heart failure, late revascularization (>180 days after CMR), and ischemic stroke. Univariable and multivariable analyses were performed to determine the predictors of MACE. A p-value of <0.05 is considered statistically significant.

Results: Mean PWV was 13.98±9.00 m/s. After a median follow-up period of 59.6 months in 263 patients (55% female, 77±5 years), 61 MACE occurred. Patients with elevated PWV (>13.98 m/s) had significantly higher rates of MACE (HR 1.75; 95% CI 1.05-2.94; p=0.03) than those with non-elevated PWV (<13.98 m/s). Multivariate analysis demonstrated diastolic blood pressure, left ventricular ejection fraction (LVEF), myocardial ischemia, and elevated PWV as independent predictors for MACE (p<0.05 for all). PWV provided an incremental prognostic value over clinical data, LVEF, and ischemia (increased global chi-square=7.25, p=0.01).

Conclusion: Aortic stiffness using CMR is a strong and independent predictor of cardiovascular events in elderly patients with known or suspected CAD.

Citing Articles

Restoration of flow in the aorta: a novel therapeutic target in aortic valve intervention.

Garg P, Markl M, Sathananthan J, Sellers S, Meduri C, Cavalcante J Nat Rev Cardiol. 2023; 21(4):264-273.

PMID: 37880496 DOI: 10.1038/s41569-023-00943-6.


Aortic Stiffness by Cardiac Magnetic Resonance: Prognostic tool or Bystander?.

Camara S, Barbosa Ribeiro H Arq Bras Cardiol. 2022; 118(5):972-973.

PMID: 35613198 PMC: 9368888. DOI: 10.36660/abc.20220231.

References
1.
Laurent S, Kingwell B, Bank A, Weber M, Struijker-Boudier H . Clinical applications of arterial stiffness: therapeutics and pharmacology. Am J Hypertens. 2002; 15(5):453-8. DOI: 10.1016/s0895-7061(01)02329-9. View

2.
Yazdanyar A, Newman A . The burden of cardiovascular disease in the elderly: morbidity, mortality, and costs. Clin Geriatr Med. 2009; 25(4):563-77, vii. PMC: 2797320. DOI: 10.1016/j.cger.2009.07.007. View

3.
Hachamovitch R, Berman D, Shaw L, Kiat H, Cohen I, Cabico J . Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation. 1998; 97(6):535-43. DOI: 10.1161/01.cir.97.6.535. View

4.
Simon A, Levenson J, Bouthier J, Safar M, Avolio A . Evidence of early degenerative changes in large arteries in human essential hypertension. Hypertension. 1985; 7(5):675-80. DOI: 10.1161/01.hyp.7.5.675. View

5.
Schram M, Henry R, van Dijk R, Kostense P, Dekker J, Nijpels G . Increased central artery stiffness in impaired glucose metabolism and type 2 diabetes: the Hoorn Study. Hypertension. 2003; 43(2):176-81. DOI: 10.1161/01.HYP.0000111829.46090.92. View